LOS ANGELES, June 05, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the software platform that powers the trades, today announced financial results for the fiscal first quarter ended April 30, ...

The global Oligonucleotide Synthesis Market, valued at US$8.9 billion in 2024 stood at US$10.5 billion in 2025 and is projected to advance at ...

The Times’ recent front-page reporting on the mysteriously “closed for renovations” Governor’s Inn, owned by a prominent GOP ...

SAN JOSE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX ), a leader in hybrid multicloud computing, today announced financial results for its third quarter ended April 30, 2025.

Although diet and lifestyle changes won't cure your Transthyretin Amyloid Cardiomyopathy (ATTR-CM), they can help you manage the symptoms and reduce the risk of it progressing to advanced congestive ...

The global ablation technology market was valued at US$ 6.82 billion in 2024 and is projected to reach US$ 16.74 billion by 2034, growing at a CAGR of 9.82% ...

acoramidis demonstrated the most rapid benefit seen in any Phase 3 study of ATTR-CM to date in both ATTRv-CM and ATTRwt-CM patients: ...

BridgeBio Pharma announced promising results from its Phase 3 trial of acoramidis for transthyretin amyloid cardiomyopathy (ATTR-CM), revealing that early and sustained increases in serum ...

As consumers work to reduce spending, the percentage of homes paying for three or more major streaming services declined in 2025, the Hub Entertainment Research survey found When you purchase through ...

Some of the drinking water stations in Raqqa canton are at risk of being taken out of service if the level of water in the Euphrates River drops further. Meanwhile, the Water Authority is disinfecting ...

72 A recent multicentre phase III trial established efficacy of tafamidis in ATTR-CM,80 with lower mortality, cardiovascular-related hospitalisations, improved quality of life and functional capacity.